Novel Gene Therapy for Leukemia Clears FDA Panel – Scientific American
|
Novel Gene Therapy for Leukemia Clears FDA Panel
Scientific American A panel of outside experts convened by the FDA voted 10-0 Wednesday to recommend the approval of Novartis' CAR-T therapy, called CTL019, for the treatment of children and young adults with advanced leukemia. The vote marks a pivotal milestone for this … |
